Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating the safety and efficacy of oral atogepant tablets in adults with migraine; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atogepant (Atogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Phase 3 | Status: RECRUITING